PTSM: Pharmaceutical Technology Sourcing and Management, Jan 6, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jan 6, 2010
Global Feature
A Pharmaceutical Ingredients Outlook
By Patricia Van Arnum
Despite a challenging current economic environment, the five-year outlook for pharmaceutical outsourcing and ingredients supply is fairly healthy.
Biotech
Financing Outlook for the US Biotechnology Industry
By Patricia Van Arnum
Buoyed by an uptick in financing from partnering deals, the US biotechnology industry reached a record high in private and public financing in 2009, but caution remains for 2010.
Outsourcing
Squeezed for Cash
By Jim Miller
Big Pharma's efforts to reduce working capital will hurt CMOs for years to come.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here